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Abstract
Leptin regulates body weight by signaling to the brain the availability of energy stored as fat. This negative feedback loop
becomes disrupted in most obese individuals, resulting in a state known as leptin resistance. The physiological causes of
leptin resistance remain poorly understood. Here we test the hypothesis that hyperleptinemia is required for the
development of leptin resistance in diet-induced obese mice. We show that mice whose plasma leptin has been clamped to
lean levels develop obesity in response to a high-fat diet, and the magnitude of this obesity is indistinguishable from wild-
type controls. Yet these obese animals with constant low levels of plasma leptin remain highly sensitive to exogenous leptin
even after long-term exposure to a high fat diet. This shows that dietary fats alone are insufficient to block the response to
leptin. The data also suggest that hyperleptinemia itself can contribute to leptin resistance by downregulating cellular
response to leptin as has been shown for other hormones.
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Introduction
Body weight in mammals is controlled by a physiological system
that balances energy intake and expenditure over the long term[1].
The core component of this system that signals the availability of
body fat is the hormone leptin[2]. Leptin is secreted by adipocytes
in proportion to their size and number, such that the
concentration of leptin in the blood is proportional to the total
amount of adipose tissue[3,4]. Binding of leptin to its target
neurons, which are expressed in the hypothalamus, brain stem and
other brain regions, inhibits feeding and stimulates energy
expenditure. Leptin thus functions as the afferent signal in a
negative feedback loop that maintains a stable level of body fat
reserves.
Leptin deficient mice (ob/ob) and humans are obese and
hyperphagic[5], and, in these individuals, leptin replacement
therapy induces dramatic weight loss[6,7,8,9]. However most
obesity is associated with elevated plasma leptin levels[3,4],
implying resistance to leptin’s weight reducing effects[10]. The
contribution of leptin resistance to obesity has also been
established by the demonstration that hyperleptinemic animals
and humans have a blunted response to exogenous leptin. Despite
the importance of delineating the causes of leptin resistance, the
cellular and molecular mechanisms responsible remain poorly
understood.
The diet-induced obese mouse is a well characterized system for
studying the development leptin resistance and pathogenesis of
obesity. In this model, C57Bl/6J mice fed a high-fat diet (45% to
60% calories from fat) become progressively obese and hyperlep-
tinemic over a span of 4 to 6 months. As these animals become
obese, they lose the ability to reduce their food intake and body
weight in response to leptin treatment. In the early stages of
obesity, mice develop resistance to leptin delivered peripherally,
but not centrally; this has been attributed to downregulation or
saturation of the transport system that transports leptin across the
blood-brain barrier[11,12]. After long-term exposure to high-fat
diet (.20 weeks), mice become resistant to leptin even when it is
directly infused into the brain via the cerebral ventri-
cle[10,12,13,14]. In these animals, the first-order, leptin-respon-
sive neurons have apparently lost the ability to activate the
signaling pathways downstream of the leptin receptor.
How does exposure to a high-fat diet impair the leptin sensitivity
of these neurons? Two models have been proposed. The first is
that leptin resistance is caused by elevated plasma leptin levels,
which result in chronic overstimulation of the leptin receptor and
activation of negative feedback pathways that block further leptin
signaling. This model is supported by the fact that leptin stimulates
the expression of SOCS-3, a protein that directly inhibits leptin
signaling[15,16,17], and that ablation of SOCS-3 in neurons
enhances leptin sensitivity and protects against diet-induced
obesity[18,19,20]. Moreover, targeted expression of a constitu-
tively active form of STAT3, which is a key mediator of leptin
signaling, is sufficient to induce leptin resistance in the hypothal-
amus[21]. This mechanism is analogous to the decrease in insulin
receptor signaling that is associated with chronic insulin treatment
and believed to result from the activation of negative feedback
pathways such as serine phosphorylation of IRS-1[22].
An alternative explanation for the development of leptin
resistance is that dietary fats themselves, rather than hyperlepti-
nemia, are responsible. Fats could either directly block leptin
signaling or activate cellular processes, such as endoplasmic
reticulum (ER) stress and inflammation, that impair leptin
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responsive neurons[23,24,25,26,27,28]. This model is supported
by the fact that pharmacological or genetic modulation of fat
metabolism in the hypothalamus has been shown to influence
energy balance and leptin sensitivity[26,29,30]. Moreover, leptin
resistance is known to develop most strongly in the arcuate nucleus
of the hypothalamus, which relative to other regions of the brain
has enhanced access to circulating nutrients[13]. In addition, it has
been observed in some[10,31], but not all[32], experimental
settings that mice fed a high-fat diet fat do not consume more
calories than mice fed a low-fat diet; this implies that dietary fat
itself, rather than increased energy intake, may be responsible for
leptin resistance in these animals.
In order to distinguish between these two possibilities, we
separated the contributions of hyperleptinemia and dietary fat to
the development of leptin resistance by (1) using osmotic infusion
pumps to clamp the plasma leptin of ob/ob mice to the level found
in lean wild-type animals over the long term, and then (2)
measuring the leptin sensitivity of these animals after being placed
on either a low- or high-fat diet.
Results
The development of central leptin resistance in C57Bl/6J mice
requires exposure to a high-fat diet for 20 weeks[10,14]. To
establish the possible contribution of hyperleptinemia versus a high
fat diet itself to the development of leptin resistance, we developed
an experimental protocol in which, beginning at weaning, the
plasma leptin levels of ob/ob mice could be fixed to the level of
lean wild-type mice (,5 ng/mL) for this duration (Figure 1a). We
performed extensive dose response studies infusing leptin into ob/
ob mice via osmotic infusion pumps and found that wild type
plasma leptin levels of approximately 5 ng/mL in ob/ob mice
could be achieved by delivering leptin at 150 ng/h. This infusion
rate could also be stably maintained for longer than six months by
replacement of the pumps every 28 days.
Pumps dispensing 150 ng/h leptin were implanted in male ob/
ob mice at four weeks of age (hereafter referred to as ‘‘ob-norm’’),
and leptin treatment normalized the body weight of these animals
within three weeks (Figure 1b). Identical pumps dispensing vehicle
(PBS) were implanted in a control group of male wild-type mice.
At six weeks of age, animals from each group were assigned to
either a high-fat diet (60% of calories from fat) or a low-fat chow
diet (13% of calories from fat) and maintained on this diet for 20
weeks with monthly pump replacements.
The body weight of the ob-norm and wild-type mice on the low-
fat diet was similar throughout the course of the experiment
(Figure 1b). There was no significant difference in average weekly
food intake between the two groups (Figure 1d; 13.560.3 kcal/d for
ob-norm versus 13.160.2 kcal/d for wild-type, p = 0.26) and their
body fat percentages were similar when measured at 14 and 18
weeks (Figure 1c). Plasma leptin levels were measured periodically
and, there was no significant difference in leptin levels between the
two cohorts on the low-fat diet (Figure 1f; p.0.22). Interestingly, a
small age-dependent increase in plasma leptin was observed in wild-
type mice on a low-fat diet, and this was also observed in the ob-
norm animals (2.660.4 ng/mL versus 1.960.4 at 18 weeks of age,
and 7.062.3 versus 6.160.9 ng/mL at 26 weeks of age for ob-norm
and wild-type, respectively; p,0.01 for the comparison between 18
and 26 weeks within either cohort). Because the only source of leptin
in the ob-norm mice was pumps that delivered a constant dose, this
small age-dependant increase likely reflects age-dependant changes
in leptin metabolism or excretion.
Exposure to a high-fat diet resulted in obesity in both wild-type
and ob-norm animals, and the time course of weight gain was
Figure 1. Energy balance in wild-type and ob-normalized animals on low and high-fat diets. A. Schematic of experimental strategy. Wild-
type and ob/ob animals were implanted with pumps dispensing PBS or leptin, respectively, at 4 weeks of age, and pumps were replaced every four
weeks as indicated by red arrows. Leptin sensitivity was assayed at 26 weeks of age. B. Body weight of wild-type (black) and ob-norm (red) mice on a
high-fat or low-fat diet. C. Body fat percentage of wild-type and ob-norm mice at 14 and 18 weeks of age that were maintained on a high-fat diet
(open bars) or low-fat diet (filled bars). D. Daily food intake for wild-type (black) and ob-norm (red) mice on a low-fat diet. p.0.05 for wild-type vs. ob-
norm at all time points. E. Daily food intake for wild-type (black) and ob-norm (red) mice on a high-fat diet. * indicates p,0.05. F. Plasma leptin
concentrations of wild-type and ob-norm mice at 18 and 26 weeks of age that were maintained on a high-fat diet (open bars) or low-fat diet (filled
bars). All error bars are +/2 SEM.
doi:10.1371/journal.pone.0011376.g001
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indistinguishable in the two groups (Figure 1b). The body weights
of wild-type and ob-norm animals were similar after 20 weeks on a
high-fat diet (52.660.4 g in wild-type versus 52.161.8 g in ob-
norm, p = 0.79). As expected, the plasma leptin levels of animals in
these two groups were very different (Figure 1f). Wild-type animals
became markedly hyperleptinemic as they became obese
(37.465.6 ng/mL at 18 weeks of age and 15466 ng/mL at 26
weeks of age), whereas the plasma leptin levels of ob-norm animals
on a high-fat diet were the same as low-fat diet, chow fed controls
(e.g., 7.062.3 ng/mL on a low-fat diet versus 8.162.3 ng/mL on
a high-fat diet at 26 weeks of age, p = 0.75).
The nearly identical body weight trajectory of wild-type and ob-
norm animals on a high-fat diet was somewhat unexpected: unlike
wild-type animals, the weight gain of ob-norm mice is not
restrained by increases in plasma leptin. We measured weekly food
intake in both cohorts after exposure to a high-fat diet, and while
the ob-norm animals did eat more food than wild-type animals at
a subset of time points (Figure 1e; p,0.01), this slightly elevated
food intake did not translate into increased body weight or
adiposity (Figure 1c). These data show that wild-type and ob-norm
animals display a very similar progression of diet-induced obesity
in response to a high-fat diet, despite the fact that they maintain a
,20-fold difference in plasma leptin levels.
Diet-induced obesity causes insulin resistance, whereas leptin
improves glucose homeostasis independent of its effects on body
weight[33,34,35,36]. We therefore compared glucose metabolism
in the four groups of animals in this experiment. Both wild-type
and ob-norm animals on a high-fat diet developed hyperglycemia
relative to low-fat diet controls (Figure 2a; p,0.001), and there
was no significant difference in fasting blood glucose between
cohorts on the same diet (p.0.15). We measured plasma insulin
levels in all four groups at 18 and 26 weeks of age (Figure 2b). Both
wild-type and ob-norm animals on a high-fat diet were
hyperinsulinemic relative to low-fat diet controls (p,0.05),
confirming that their hyperglycemia was a consequence of insulin
resistance. By contrast, there was no significant difference in
plasma insulin between cohorts on the same diet (p.0.24). These
data indicate that the differences in blood glucose and insulin
levels were determined by diet, not plasma leptin levels.
We performed glucose tolerance tests to measure the ability of
each cohort to clear a bolus of sugar from the blood (Figure 2c).
For mice on a low-fat diet, plasma glucose levels were
indistinguishable between wild-type and ob-norm cohorts
throughout the test (p.0.5). This confirms that leptin replacement
at physiological levels was sufficient to normalize glucose
homeostasis in the lean ob-norm animals. By contrast, both
cohorts exposed to a high-fat diet showed delayed glucose
clearance (Figure 2c; p,0.01). The magnitude of this impairment
was greater in ob-norm animals relative to wild-type controls at 60
and 120 minutes (Figure 2c; p,0.01). Thus, while the high-fat fed
wild-type and ob-norm animals have similar fasting hyperglycemia
and hyperinsulinemia, the ob-norm animals have an additional
defect in glucose metabolism that is revealed by glucose challenge
suggesting that their relative leptin deficiency may further impair
glucose metabolism of DIO mice.
Leptin-deficient ob/ob mice are hypoactive and have reduced
energy expenditure. We therefore performed respirometry and
activity measurements to compare the four groups of animals in
this experiment (Figure 2). Activity was quantified by measuring
beam breaks in three dimensions in animals that had been
acclimated in metabolic cages. For the groups on a low-fat diet,
there was no significant difference in average beam breaks
Figure 2. Glucose metabolism and energy expenditure. A. Plasma glucose concentrations in ad libitum fed wild-type and ob-norm mice that
were maintained on a high-fat diet (open bars) or low-fat diet (filled bars). B. Plasma insulin concentrations of wild-type and ob-norm mice at 18 and
26 weeks of age that were maintained on a high-fat diet (open bars) or low-fat diet (filled bars). C. Plasma glucose concentrations in response to a
glucose injection in wild-type (black) and ob-norm (red) mice. Triangles represent mice on a low-fat diet and squares represent mice on a high-fat
diet. * indicates p,0.05. D. Average beam breaks per minute for wild-type and ob-norm mice maintained on a low-fat (filled bar) or high-fat (open
bar) diet. E. Average oxygen consumption for wild-type and ob-norm mice in the light phase (open bars) and dark phase (closed bars).
doi:10.1371/journal.pone.0011376.g002
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between the wild-type and ob-norm groups (Figure 2d). For
animals on a high-fat diet, there was a trend toward decreased
activity in the ob-norm group, but this did not reach significance
(35.964.3 breaks/min in wild-type versus 27.762.6 breaks/min
in the ob/ob norm, p = 0.12). Similarly, we found that there was
no significant difference in oxygen consumption, during either the
light or dark phases, between wild-type and ob-norm cohorts on
the same diet (Figure 2e).
Having established that wild-type and ob-norm animals have a
similar body weight and physiology when maintained on the same
diet, other than a modest impairment of glucose metabolism
among ob-norm animals on a high fat diet, we next tested whether
long-term exposure to a high- or low-fat diet affected the leptin
sensitivity of these two groups. We used two assays for this
purpose. First, in order to measure functional sensitivity to leptin,
we tested whether a short-term leptin infusion could reduce food
intake and body weight in each of the four cohorts. We did this by
replacing the mini-osmotic pumps in all animals with pumps that
delivered leptin at either the same rate (‘‘vehicle’’) or at a rate
450 ng/h higher. This results in a 4-fold increase in the leptin
infusion rate in ob-norm animals (150 ng/h versus 600 ng/h
leptin) and has previously been shown to result in a 4-fold increase
in plasma leptin in lean wild-type animals[37]. We then measured
food intake and body weight for 12 days, at which point the pumps
were replaced with pumps dispensing leptin or PBS at the baseline
rate.
As expected, wild-type mice maintained on a low-fat diet
remained sensitive to exogenous leptin, reducing their food intake
(15.160.6 kcal/d for vehicle versus 12.560.5 kcal/d for leptin,
p,0.05) and showed a progressive reduction of body weight
throughout the 12-day infusion (Figure 3). By contrast, wild-type
mice that had been maintained on a high-fat diet for 20 weeks
showed no reduction in food intake or body weight in response to
the 450 ng/h leptin infusion (Figure 3). These results are
consistent with previous reports showing that prolonged diet-
induced obesity induces robust leptin resistance in mice[10].
ob-norm mice that had been maintained on a low-fat diet were
sensitive to leptin, and showed a similar reduction of food intake as
their wild-type counterparts, (15.261.4 kcal/d for vehicle versus
12.161.1 kcal/d for leptin, p = 0.08) and losing approximately 10
percent of their body mass over the course of the 12-day infusion
(22.861.1% for control versus 211.661.0% for leptin, p,0.05).
In contrast, and unlike wild-type controls on a high fat diet, ob-
norm mice that had been exposed to a high-fat diet remained
highly sensitive to exogenous leptin. These animals showed a
significantly reduced food intake (18.361.5 kcal/d for vehicle
versus 13.860.8 kcal/d for leptin, p,0.05) and body weight
(0.660.6% for vehicle versus 27.361.8% for leptin, p,0.05) in
response to the leptin infusion. Because wild-type and ob-norm
animals differed only in their plasma leptin levels, this result
confirms that hyperleptinemia is functionally required for the
development of leptin resistance after long-term exposure to a
high-fat diet.
In a second assay of leptin sensitivity, we next tested whether
leptin could stimulate acute phosphorylation of STAT3 in neurons
of the mediobasal hypothalamus among the four groups of
mice[10,13,38]. Mice were given an intraperitoneal bolus of either
vehicle (PBS) or leptin (2 mg/kg) and sacrificed 30 minutes later by
cardiac perfusion. This dose of leptin has previously been shown to
increase plasma leptin levels by 40-fold[10]. Brains were dissected,
and STAT3 phosphorylation was quantified by immunohistochem-
istry (Figure 4). Wild-type animals maintained on a low-fat diet
showed a robust increase in the number of pSTAT3 positive cells in
response to leptin (Figure 4a; 4.061.7 cells for vehicle versus 67615
Figure 3. Leptin sensitivity in a 12-day infusion. A. Body weight of wild-type animals that received a leptin (red) or PBS (black) infusion for 12-
days (gray block). B. Body weight of ob-norm animals that received a leptin (red) or PBS (black) infusion for 12-days (gray block). C. Difference in
weight loss between leptin and vehicle for each cohort over the 12-day leptin infusion. Values are expressed as percentage change in body weight.
D. Average daily food intake during the 12-day infusion for animals in each cohort.
doi:10.1371/journal.pone.0011376.g003
Leptin Resistance
PLoS ONE | www.plosone.org 4 June 2010 | Volume 5 | Issue 6 | e11376
cells for leptin, p,0.02). By contrast, wild-type mice maintained on
a high-fat diet showed no increase in pSTAT3 positive cells in
response to leptin (24.265.8 cells for vehicle versus 21.866.8 cells
for leptin, p = 0.8), confirming that diet-induced obesity blunts the
leptin-responsiveness of these first-order neurons. While wild-type
mice on a high-fat diet were insensitive to exogenous leptin, these
mice did have a modestly increased number of pSTAT3 positive
cells at baseline compared to low-fat fed animals (Figure 4c,
p,0.05). This supports prior suggestions that diet-induced obesity
results in chronically elevated leptin signaling that cannot be further
modulated by additional leptin[39,40,41].
We next tested ob-norm mice in the same assay. Ob-norm mice
maintained on a low-fat diet showed increased STAT3 phosphor-
ylation in response to leptin, and the magnitude of this increase
was similar to wild-type controls (10.764.5 cells for vehicle versus
7161.7 cells for leptin, p,0.01). Unlike wild-type animals on a
high fat diet, ob-norm mice that had been maintained on a high-
fat diet also showed a robust increase in STAT3 phosphorylation
in response to leptin (2.760.8 cells for vehicle versus 108621 cells
for leptin, p,0.01). There was no indication that the leptin
responsiveness of these high-fat diet fed, ob-norm mice was
impaired in this assay relative to lean controls. These biochemical
data are consistent with the physiological data from leptin infusion
experiments and indicate that even long-term exposure to a high-
fat diet is not sufficient to block the leptin-induced activation of
JAK/STAT signaling in normoleptic animals. Instead, we
conclude that hyperleptinemia is required for the development
of leptin resistance in response to diet-induced obesity.
Discussion
The mechanisms responsible for the development of leptin
resistance have been the focus of many studies. As leptin resistance
results in obesity and other metabolic diseases, agents which can
re-sensitize the obese to leptin would have great therapeutic value.
However, the molecular events responsible for the development of
leptin resistance remain poorly understood, in part because of the
numerous physiological and nutritional differences between lean
and diet-induced obese animals. In principle, any of these
differences could contribute to impaired leptin sensitivity.
In this study we asked whether one physiological parameter –
elevated plasma leptin levels – is required for the development of
leptin resistance in response to a high-fat diet. We focused on
hyperleptinemia because negative feedback in response to excess
signaling is a classical mechanism of hormone resistance (including
insulin), and because there was already evidence supporting at least
one molecular mechanism for negative feedback regulation of leptin
(SOCS-3). These experiments were made possible by our having
developed a protocol that could normalize the plasma leptin levels
of ob/ob mice over the long-term using subcutaneous pumps. We
found, consistent with previous studies, that leptin replacement in
ob/ob animals is sufficient to normalize their body weight and other
physiologic abnormalities, and furthermore that this normalization
can be maintained for 6 months by replacing the pumps monthly.
The data clearly show that the hyperleptinemia in mice fed a high
fat diet is required for the development of leptin resistance. These
results do not support the claim that a high-fat diet can block the
response to leptin in ob/ob animals[42]. Recently, the peptide
amylin has been shown to sensitize animals and humans to the
effects of leptin[43,44]. An important challenge will be to further
understand the cellular basis of leptin resistance and the mechanism
by which amylin can improve it.
In addition to its role in regulating energy balance in adult
animals, leptin has trophic effects on hypothalamic neurons during
early post-natal development[45]. We have shown that leptin
treatment beginning at 4 weeks of age normalizes the food intake
Figure 4. STAT3 phosphorylation in response to acute leptin injection. A. Staining for pSTAT3 in the mediobasal hypothalamus of mice on a
low-fat diet given an intraperitoneal injection of either leptin or vehicle. B. Staining for pSTAT3 in the mediobasal hypothalamus of mice on a high-fat
diet given an intraperitoneal injection of either leptin or vehicle. C. Quantitation of pSTAT3 positive cells in the arcuate nucleus for mice on a low-fat
diet. D. Quantitation of pSTAT3 positive cells in the arcuate nucleus for mice on a high-fat diet.
doi:10.1371/journal.pone.0011376.g004
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and adiposity of ob/ob mice on a low fat diet, but it remains possible
that neonatal leptin deficiency could selectively influence the
development of leptin resistance in response to a high-fat diet.
Previous studies have found that leptin treatment of ob/ob mice
rapidly normalizes the number of excitatory and inhibitory synaptic
inputs to arcuate POMC and NPY neurons[46], suggesting that
there is significant plasticity in the adult hypothalamus. Consistent
with this, we have found that the leptin sensitivity of ob/ob mice
subjected to long-term leptin replacement is indistinguishable from
lean wild-type controls (in contrast to leptin-naı¨ve ob/ob animals,
which are hypersensitive to leptin). Nonetheless, certain hypotha-
lamic projections are impaired in ob/ob mice, and leptin treatment
of adult ob/ob animals does not correct these defects[45]. The
significance of these anatomical differences to energy balance and
leptin sensitivity remains unclear.
Recent work on leptin resistance has focused on the role of
inflammation in the hypothalamus[47,48]. This is based on the
observation that fats, either when supplied in excess in the diet or
administered centrally, can induce hypothalamic inflammation,
and that genetic or pharmacological blockade of inflammatory
signaling in the brain can improve leptin sensitivity[26,27,28,49].
In addition, ER stress is a common byproduct of inflammation,
and ER stress has been shown to contribute independently to the
development of leptin resistance[23,24,25]. Our data are not
inconsistent with a role for inflammation and ER stress in the
development of leptin resistance. However, our data do imply that
hyperleptinemia is required for any inflammation-mediated
mechanism that blocks leptin signaling after exposure to a high-
fat diet. In this respect, the fact that upregulation of SOCS-3 is one
of the primary mechanisms by which inflammation has been
proposed to inhibit leptin signaling suggests that hyperleptinemia
and inflammatory cytokines may contribute to leptin resistance by
activating a common set of pathways.
One unexpected finding from our study was that ob-norm
animals, which had a fixed level of plasma leptin, nonetheless
gained weight in response to a high-fat diet at a rate that was
indistinguishable from wild-type animals on the same diet, and the
two groups reached an identical body weight plateau (Figure 1b).
If incremental changes in leptin significantly restrained body
weight in response to excess dietary fat, then the ob-norm animals
would be predicted to gain weight more quickly than wild-type
controls and plateau at a higher body weight, if at all. The fact that
this was not observed indicates that a leptin-independent
mechanism specifies the body weight set point in animals fed a
high-fat diet. While the nature of this mechanism is unclear, this
observation is consistent with previous reports showing that
transgenic mice that overexpress leptin in the liver (and therefore
do not experience substantial increases in plasma leptin in
response to obesity) nonetheless gain weight at a rate that is
indistinguishable from wild-type animals when exposed to a high-
fat diet[50]. Likewise, leptin infusion fails to prevent the weight
gain that occurs when wild-type animals are exposed to a high-fat
diet[51]. However, viral overexpression of leptin in the rat
hypothalamus has been reported to potentiate the weight gain
caused by a high-fat diet[52]. As body weight is regulated by
numerous short and long-term signals, it will be important to
establish how energy balance can be maintained in a leptin
independent manner.
In summary, our finding that hyperleptinemia, and therefore
excess leptin signaling, is required for the development of leptin
resistance reinforces the view that understanding the changes in
signal transduction within the sparse neuronal cell types that
control energy balance will be essential to unraveling the
mechanism of leptin resistance. One of the major challenges in
studying leptin resistance has been the difficulty of accessing
leptin’s key target cells, which are a small subpopulation of
neurons located primarily in the hypothalamus and brain stem.
The development of BacTrap technology for neuron-specific
profiling represents an exciting opportunity to begin to character-
ize the molecular changes that develop in these cells with acute
and chronic hyperleptinemia, and these experiments are under-
way[53].
Methods
Ethics Statement
All procedures were carried out in accordance with the National
Institutes of Health Guidelines on the Care and Use of Animals
and approved by the Rockefeller University Institutional Animal
Care and Use Committee (Protocol #09012).
Animals: Diet and leptin normalization
Wild-type and ob/ob C57BL/6J mice were obtained from
Jackson laboratories (Bar Harbor, ME). At 4 weeks of age, a
micro-osmotic pump (model 1004; Durect, Cupertino, CA)
dispensing either vehicle (PBS) for wild-type animals or leptin
(150 ng/h in PBS) for ob/ob animals was implanted subcutane-
ously and mice were individually housed. Recombinant murine
leptin was obtained from Amylin Pharmaceuticals (San Diego,
CA). At 6 weeks of age, mice from each cohort were assigned to
either remain on a low-fat chow diet (Picolab Rodent Diet 20,
LabDiet, St. Louis, MO) or switched to a high-fat diet (D12492,
Research Diets, New Brunswick, NJ). The low-fat diet contained
3.41 kcal/g (24.6% calories from protein, 13.2% calories from fat,
and 62.1% calories from carbohydrates) and the high-fat diet
contained 5.24 kcal/g (20% calories from protein, 60% calories
from fat, and 20% calories from carbohydrates). Food intake and
body weight were monitored weekly. Micro-osmotic pumps were
replaced at week 8 and every 4 weeks thereafter to ensure
continuous delivery of leptin or vehicle; model 2004 pumps were
used after week 8. Body composition was measured by dual-energy
x-ray absorptiometry (DEXA) densitometry (Lunar PIXImus 2,
GE Medical Systems, Wisconsin).
Glucose, Insulin, and Leptin Measurements
Glucose tolerance tests were performed on mice that had been
fasted for 14 hr beginning at the onset of the dark cycle. The
following day mice were given an intraperitoneal injection of an
aqueous solution of 20% glucose (6.25 mL/g body weight) and
blood glucose was measured from the tail vein at 0, 15, 30, 60, and
120 min using an Ascensia Elite XL glucometer (Bayer Health-
Care, Tarrytown, NY).
Plasma hormone levels were measured using ELISA kits for
leptin (R&D Systems, Minneapolis, MN) or insulin (Mercodia,
Winston Salem, NC) from blood collected from the tail vein of ad
libitum fed animals.
Respirometry and Activity Measurements
Mice were individually housed in Oxymax metabolic cages
(Columbus Instruments, Columbus, OH) with ad libitum access to
food and water. Gas consumption and movement was recorded for
3–4 days. Animals that stopped eating or drinking during this
interval or that lost significant body weight (.2 g) were excluded
from the analysis.
Leptin Infusion Assays
To measure the sensitivity of animals to short-term leptin
infusion, the micro-osmotic pump in each animal was replaced
Leptin Resistance
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with a 14-day pump (Model 2002, Durect) dispensing leptin at a
rate 450 ng/h above baseline. This means that for wild-type
animals, pumps delivering PBS were replaced with pumps
delivering leptin at 450 ng/h, and for ob/ob animals, pumps
delivering leptin at 150 ng/h were replaced with pumps delivering
leptin at 600 ng/h. Body weight was recorded daily and food
intake every 6 days. After 12 days pumps were removed and
replaced with pumps dispensing leptin at baseline (PBS for wild-
type animals and 150 ng/h for ob/ob animals).
Immunohistochemistry
Mice were injected with either leptin (2 mg/kg, intraperitoneal)
or vehicle (PBS). 30 min after injection animals were anesthetized
with isoflurane and perfused with 10% neutral buffered formalin
(Sigma, St. Louis, MO). Brains were removed by dissection and
soaked in formalin overnight at 4uC. 50 mm sections were
prepared and stained for pSTAT3 as follows[10]. Free-floating
sections were treated with 1% H2O2+1% NaOH in water for
10 min, followed by 0.3% glycine in PBS for 10 min, and 0.03%
SDS in PBS for 10 min. Sections were then exposed to blocking
solution (PBS containing 0.1% Triton X-100/2% Goat Serum/
3% BSA) for 1 hr. Phospho-STAT3 (Tyr 705) antibody (#9131,
Cell Signaling, Danvers, MA) was diluted 1:1000 into blocking
solution and sections were stained for 48 hr at 4uC. Sections were
then washed (3 times, 20 min) and incubated with secondary
antibody for 2 hr (Alexa 488 conjugated goat anti-rabbit antibody;
Invitrogen, Carlsbad, CA). Sections were washed (3 times,
20 min), mounted on microscope slides, and photographed.
To quantitate the number of stained cells, a 3006300 pixel
section was removed from the region representing the arcuate
nucleus in each image. The number of positive cells was then
counted by an observer blinded to the sample identity.
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